These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21031024)

  • 1. A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.
    Xu Y; Zhao H; Zheng Y; Gu Q; Ma J; Xu X
    Mol Vis; 2010 Oct; 16():1982-95. PubMed ID: 21031024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.
    Sun Y; Su L; Wang Z; Xu Y; Xu X
    BMC Cell Biol; 2013 Feb; 14():8. PubMed ID: 23433118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization.
    Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
    Curr Eye Res; 2021 Oct; 46(10):1551-1558. PubMed ID: 33870816
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V.
    Wang Z; Zhao H; Ma JX; Xu X
    Cornea; 2014 Apr; 33(4):405-13. PubMed ID: 24452210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Small Peptide H-KI20 Inhibits Retinal Neovascularization Through the JNK/ATF2 Signaling Pathway.
    Wang R; Xu Y; Niu C; Gao X; Xu X
    Invest Ophthalmol Vis Sci; 2021 Jan; 62(1):16. PubMed ID: 33439229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.
    Zheng Y; Gu Q; Xu X
    Acta Ophthalmol; 2012 Nov; 90(7):e512-23. PubMed ID: 22994140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel and effective human hepatocyte growth factor kringle 1 domain inhibits ocular neovascularization.
    Lu Q; Zhang L; Shen X; Zhu Y; Zhang Q; Zhou Q; Gan R; Zhang H; Zhong Y; Xie B
    Exp Eye Res; 2012 Dec; 105():15-20. PubMed ID: 23085338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Peptide NT/K-CRS Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization
    Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
    J Ocul Pharmacol Ther; 2021 Sep; 37(7):412-420. PubMed ID: 34252290
    [No Abstract]   [Full Text] [Related]  

  • 9. The tumour neovasculature-homing dimeric peptide GX1 demonstrates antiangiogenic activity in the retinal neovasculature.
    Luo Y; Yin J; Fang R; Liu J; Wang L; Zhang H; Zhang M; Lei Z; Liang S; Cui W; Zhang Z; Wu K; Hui X
    Eur J Pharmacol; 2021 Dec; 912():174574. PubMed ID: 34662566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro.
    Li F; Bai Y; Zhao M; Huang L; Li S; Li X; Chen Y
    Ophthalmic Res; 2015; 53(3):109-16. PubMed ID: 25676100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.
    Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H
    Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization.
    Palmer GM; Tiran Z; Zhou Z; Capozzi ME; Park W; Coletta C; Pyriochou A; Kliger Y; Levy O; Borukhov I; Dewhirst MW; Rotman G; Penn JS; Papapetropoulos A
    Br J Pharmacol; 2012 Mar; 165(6):1891-1903. PubMed ID: 21943108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
    Su L; Xu X; Zhao H; Gu Q; Zou H
    Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenesis effects of endostatin in retinal neovascularization.
    Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
    Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
    Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Pathologic Corneal Neovascularization by Topical Application of a Novel Peptide In Vivo.
    Lu Y; Xu Y; Gu Q; Xu X
    Cornea; 2015 Oct; 34(10):1295-302. PubMed ID: 26266428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t.
    Zhang L; Shen X; Lu Q; Zhou Q; Gu J; Gan R; Zhang H; Sun X; Xie B
    Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):731-9. PubMed ID: 21881847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.